Tamara Seymour - Favrille Inc (fvrl) - The Wall Street Transcript

The Wall Street Transcript - In-Depth Interviews for Investors

Healthcare >> CEO Interviews >> June 27, 2005

TWST: We'd like to begin with a brief historical sketch of the company

and a picture of the things you're doing at the present time.

Ms. Seymour: Favrille is a late stage biopharmaceutical

Join for free to read a longer excerpt or purchase this article